Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 56565P103 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Catalyst4, Inc.
13D/A
|
49.9% |
8/18/2026
Event 8/14/2026
|
||
| Catalyst4, Inc. | 49.9% | |||
| Robert Brown | 49.9% | |||
| Ekemini Riley | 49.9% | |||
| Mark Vorsatz | 49.9% | |||
| T. Rowe Price Investment Management, Inc. 13G/A | 7.4% |
5/15/2026
Event 3/31/2026
|
||
|
Forbion Growth Opportunities Fund III Cooperatief U.A.
13G
|
7.1% |
2/17/2026
Event 12/31/2025
|
||
| Forbion Growth Opportunities Fund III Cooperatief U.A. | 7.1% | |||
| Forbion Growth III Management B.V. | 7.1% | |||
|
Pivotal bioVenture Partners Fund II, L.P.
13G
|
5.5% |
8/20/2026
Event 8/13/2026
|
||
| Nan Fung Group Holdings Limited | 5.5% | |||
| NF Investment Holdings Limited | 5.5% | |||
| Nan Fung Life Sciences Holdings Limited | 2.4% | |||
| NFLS Platform Holdings Limited | 1.3% | |||
| Pivotal Life Sciences Holdings Limited | 1.2% | |||
| Pivotal Partners Ltd | 1.2% | |||
| Pivotal bioVenture Partners Fund II G.P. Ltd | 1.2% | |||
| Pivotal bioVenture Partners Fund II, L.P. | 1.2% | |||
| NFLS Beta Limited | 1.3% | |||
| Permwell Management Limited | 3.1% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (1) | ||||
| Novo Holdings A/S 13D/A | 4.9% |
7/31/2026
Event 7/30/2026
|
||